Maud M Geenen Selected Research

Abiraterone Acetate

1/2021

Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer: Results from the Dutch Castration-resistant Prostate Cancer Registry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maud M Geenen Research Topics

Disease

5	Neoplasms (Cancer) 01/2020 - 08/2003
3	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2018
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2020
2	Fatigue 01/2018 - 06/2015
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Pain (Aches) 01/2020
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Breast Neoplasms (Breast Cancer) 06/2015
1	Lower Urinary Tract Symptoms 11/2012
1	Wilms Tumor (Wilm's Tumor) 10/2010

Drug/Important Bio-Agent (IBA)

1	Abiraterone AcetateIBA 01/2021
1	enzalutamideIBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	Prednisone (Sone)FDA LinkGeneric 01/2021
1	AndrogensIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020

Therapy/Procedure

3	Therapeutics 01/2021 - 11/2012
3	Castration 01/2021 - 01/2018
3	Drug Therapy (Chemotherapy) 01/2018 - 08/2003
2	Adjuvant Chemotherapy 01/2018 - 06/2015
2	Radiotherapy 10/2010 - 08/2003
1	Neoadjuvant Therapy 01/2022